In vitro efficacy of diallyl sulfides against the periodontopathogen Aggregatibacter actinomycetemcomitans

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2397-2407

  Velliyagounder, Kabilan ^a   Ganeshnarayan, Krishnaraj ^a   Velusamy, Senthil Kumar ^a   Fine, Daniel H ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; ALLYL SULFIDE; GARLIC EXTRACT; GLUTATHIONE TRANSFERASE;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; BIOFILM; CELL COUNT; CELL CULTURE; CELL CYCLE ARREST; CELL DEATH; CELL STRESS; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; HEAT; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MOUTH INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; SCANNING ELECTRON MICROSCOPE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; AGGRESSIVE PERIODONTITIS; ALLYL COMPOUNDS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; CELL SURVIVAL; EPITHELIAL CELLS; GARLIC; GINGIVA; GLUTATHIONE TRANSFERASE; HOT TEMPERATURE; HUMANS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; PLANT EXTRACTS; SULFIDES; SULFINIC ACIDS;

EID: 84860137518     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00020-12     Document Type: Article

References (83)

1. Alam M, Dwivedi V, Khan AA, Mohammad O. 2009. Efficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice. Nanomed 4:713-724.
2. Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RM, Mustafa T. 2000. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins Leukot. Essent. Fatty Acids 62:253-259. (Pubitemid 30410532)
3. Alpers DH. 2009. Garlic and its potential for prevention of colorectal cancer and other conditions. Curr. Opin. Gastroenterol. 25:116 -121.
4. Amagase, H. 2006. Clarifying the real bioactive constituents of garlic. J. Nutr. 136:716S-725S. (Pubitemid 43363763)
5. Ankri S, Mirelman D. 1999. Antimicrobial properties of allicin from garlic. Microbes Infect. 1:125-129.
6. Ardila CM, Granada MI, Guzman IC. 2010. Antibiotic resistance of subgingival species in chronic periodontitis patients. J. Periodont. Res. 45:557-563.
7. Avato P, Tursil E, Vitali C, Miccolis V, Candido V. 2000. Allylsulfide constituents of garlic volatile oil as antimicrobial agents. Phytomedicine 7:239 -243.
8. Bakri IM, Douglas CW. 2005. Inhibitory effect of garlic extract on oral bacteria. Arch. Oral Biol. 50:645- 651.
9. Banerjee SK, Mukherjee PK, Maulik SK. 2003. Garlic as an antioxidant: the good, the bad and the ugly. Phytother. Res. 17:97-106. (Pubitemid 36262255)
10. Belloir C, Singh V, Daurat C, Siess MH, Le Bon AM. 2006. Protective effects of garlic sulfur compounds againstDNAdamage induced by directand indirect-acting genotoxic agents in HepG2 cells. Food Chem. Toxicol. 44:827- 834.
11. Benkeblia N, Onodera S, Yoshihira T, Kosaka S, Shiomi N. 2004. Effect of temperature on soluble invertase activity, and glucose, fructose and sucrose status of onion bulbs (Allium cepa) in store. Int. J. Food Sci. Nutr. 55:325-331. (Pubitemid 39294771)
12. Block E. 1985. The chemistry of garlic and onions. Sci. Am. 252:114 -119.
13. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248 -254.
14. Castillo-Ruiz M, et al. 2011. Isolation of a novel Aggregatibacter actinomycetemcomitans serotype b bacteriophage capable of lysing bacteria within a biofilm. Appl. Environ. Microbiol. 77:3157-3159.
15. Cellini L, Di Campli E, Masulli M, Di Bartolomeo S, Allocati N. 1996. Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol. Med. Microbiol. 13:273-277. (Pubitemid 26157931)
16. Chandrashekar PM, Venkatesh YP. 2009. Identification of the protein components displaying immunomodulatory activity in aged garlic extract. J. Ethnopharmacol. 124:384 -390.
17. Chen GW, Chung JG, Ho HC, Lin JG. 1999. Effects of the garlic compounds diallyl sulphide and diallyl disulphide on arylamine N-acetyltransferase activity in Klebsiella pneumoniae. J. Appl. Toxicol. 19: 75-81.
18. Chen L, et al. 1999. Decrease of hepatic catalase level by treatment with diallyl sulfide and garlic homogenates in rats and mice. J. Biochem. Mol. Toxicol. 13:127-134. (Pubitemid 129705384)
19. Chung JG, et al. 1998. Effects of garlic compounds diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Am. J. Chin. Med. 26:353-364. (Pubitemid 128730959)
20. Cortelli SC, et al. 2009. Diminished treatment response of periodontally diseased patients infected with the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J. Clin. Microbiol. 47:2018 -2025.
21. Cutler RR, Wilson P. 2004. Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus. Br. J. Biomed. Sci. 61:71-74. (Pubitemid 38879530)
22. Desvarieux M, et al. 2005. Periodontal microbiota and carotid intimamedia thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111:576 -582.
23. Dickson MA, et al. 2000. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:1436 -1447.
24. Durak I, Ozturk HS, Olcay E, Can B, Kavutcu M. 2002. Effects of garlic extract on oxidant/antioxidant status and atherosclerotic plaque formation in rabbit aorta. Nutr. Metab. Cardiovasc. Dis. 12:141-147. (Pubitemid 135712757)
25. Elango EM, et al. 2004. Inhibition of cyclooxygenase-2 by diallyl sulfides (DAS) in HEK 293T cells. J. Appl. Genet. 45:469-471. (Pubitemid 39643736)
26. Fine DH, Furgang D, Goldman D. 2007. Saliva from subjects harboring Actinobacillus actinomycetemcomitans kills Streptococcus mutans in vitro. J. Periodontol. 78:518 -526.
27. Fine DH, Furgang D, Kaplan J, Charlesworth J, Figurski DH. 1999. Tenacious adhesion of Actinobacillus actinomycetemcomitans strain CU1000 to salivary-coated hydroxyapatite. Arch. Oral Biol. 44:1063-1076. (Pubitemid 30029581)
28. Fine DH, et al. 1999. Phenotypic variation in Actinobacillus actinomycetemcomitans during laboratory growth: implications for virulence. Microbiology 145(Pt. 6):1335-1347. (Pubitemid 29294919)
29. Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C. 1999. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol. 2000 20: 136-167.
30. Fukao T, Hosono T, Misawa S, Seki T, Ariga T. 2004. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride. Food Chem. Toxicol. 42:743-749. (Pubitemid 38376341)
31. Germain E, Auger J, Ginies C, Siess MH, Teyssier C. 2002. In vivo metabolism of diallyl disulphide in the rat: identification of two new metabolites. Xenobiotica 32:1127-1138. (Pubitemid 36020939)
32. Gillett R, Johnson NW. 1982. Bacterial invasion of the periodontium in a case of juvenile periodontitis. J. Clin. Periodontol. 9:93-100. (Pubitemid 12169563)
33. Habig WH, Jakoby WB. 1981. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77:398-405.
34. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7130-7139.
35. Haubek D, Poulsen K, Asikainen S, Kilian M. 1995. Evidence for absence in northern Europe of especially virulent clonal types of Actinobacillus actinomycetemcomitans. J. Clin. Microbiol. 33:395- 401.
36. Herrera D, Alonso B, Leon R, Roldan S, Sanz M. 2008. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J. Clin. Periodontol. 35:45- 66.
37. Hsieh SE, Lo HH, Chung JG. 1998. The characteristics of arylamine N-acetyltransferase in Pseudomonas aeruginosa. Curr. Microbiol. 36: 353-360.
38. Jefferson KK, Goldmann DA, Pier GB. 2005. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 49:2467-2473. (Pubitemid 40734481)
39. Kaplan AH, Weber DJ, Oddone EZ, Perfect JR. 1989. Infection due to Actinobacillus actinomycetemcomitans: 15 cases and review. Rev. Infect. Dis. 11:46-63.
40. Kaplan JB, Schreiner HC, Furgang D, Fine DH. 2002. Population structure and genetic diversity of Actinobacillus actinomycetemcomitans strains isolated from localized juvenile periodontitis patients. J. Clin. Microbiol. 40:1181-1187. (Pubitemid 34279872)
41. Kulik EM, Lenkeit K, Chenaux S, Meyer J. 2008. Antimicrobial susceptibility of periodontopathogenic bacteria. J. Antimicrob. Chemother. 61: 1087-1091. (Pubitemid 351524454)
42. Kyung KH, Kim MH, Park MS, Kim YS. 2002. Allinase-independent inhibition of Staphylococcus aureus B33 by heated garlic. J. Food Science 67:6.
43. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
44. Lai PK, Roy J. 2004. Antimicrobial and chemopreventive properties of herbs and spices. Curr. Med. Chem. 11:1451-1460. (Pubitemid 38735789)
45. Lamm DL, Riggs DR. 2001. Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies. J. Nutr. 131:1067S-1070S. (Pubitemid 32195009)
46. Lawson LD. 2007. Allyl sulfides and allyl thiosulfinates before and after heating at 54 degrees C for two weeks. Garlic Research Labs, Inc., Glendale, CA. http://www.mosquitobarrier.com/documents/MB-analysis-Silliker.pdf.
47. Lawson LD, Ransom DK, Hughes BG. 1992. Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products. Thromb. Res. 65:141-156.
48. Lawson LD, Wang ZJ. 2005. Allicin and allicin-derived garlic compounds increase breath acetone through allyl methyl sulfide: use in measuring allicin bioavailability. J. Agric. Food Chem. 53:1974 -1983.
49. Lawson LD, Wang ZJ, Hughes BG. 1991. Identification and HPLC quantitation of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Med. 57:363-370.
50. Lei XY, et al. 2008. Apoptosis induced by diallyl disulfide in human breast cancer cell line MCF-7. Acta Pharmacol. Sin. 29:1233-1239.
51. Lemar KM, et al. 2007. Diallyl disulphide depletes glutathione in Candida albicans: oxidative stress-mediated cell death studied by two-photon microscopy. Yeast 24:695-706. (Pubitemid 47322306)
52. Liu WH, Hsu CC, Yin MC. 2008. In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid. Phytother. Res. 22: 53-57.
53. Lo HH, Hsieh SE, Chung JG. 1998. The effect of sulindac on arylamine N-acetyltransferase activity in Pseudomonas aeruginosa. Microbios 93: 159-168.
54. Lu X, et al. 2011. Infrared and Raman spectroscopic studies of the antimicrobial effects of garlic concentrates and diallyl constituents on foodborne pathogens. Anal. Chem. 83:4137- 4146.
55. Madinier IM, Fosse TB, Hitzig C, Charbit Y, Hannoun LR. 1999. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans. J. Periodontol. 70:888-892. (Pubitemid 29400113)
56. Meyer DH, Lippmann JE, Fives-Taylor PM. 1996. Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: a dynamic, multistep process. Infect. Immun. 64:2988 -2997.
57. Mosca A, Miragliotta L, Iodice MA, Abbinante A, Miragliotta G. 2007. Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy. Int. J. Antimicrob. Agents 30:521-524. (Pubitemid 350051776)
58. O'Gara EA, Hill DJ, Maslin DJ. 2000. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl. Environ. Microbiol. 66:2269 -2273.
59. Pai ST, Platt MW. 1995. Antifungal effects of Allium sativum (garlic) extract against the Aspergillus species involved in otomycosis. Lett. Appl. Microbiol. 20:14 -18.
60. Peleg A, et al. 2003. Effect of garlic on lipid profile and psychopathologic parameters in people with mild to moderate hypercholesterolemia. Isr. Med. Assoc. J. 5:637- 640.
61. Rams TE, Dujardin S, Sautter JD, Degener JE, van Winkelhoff AJ. 2011. Spiramycin resistance in human periodontitis microbiota. Anaerobe 17: 201-205.
62. Rattanachaikunsopon P, Phumkhachorn P. 2009. Antimicrobial activity of elephant garlic oil against Vibrio cholerae in vitro and in a food model. Biosci. Biotechnol. Biochem. 73:1623-1627.
63. Rattanachaikunsopon P, Phumkhachorn P. 2008. Diallyl sulfide content and antimicrobial activity against food-borne pathogenic bacteria of chives (Allium schoenoprasum). Biosci. Biotechnol. Biochem. 72:2987-2991.
64. Sakurai K, et al. 2007. High incidence of actinobacillus actinomycetemcomitans infection in acute coronary syndrome. Int. Heart J. 48:663- 675.
65. Shobana S, Naidu KA. 2000. Antioxidant activity of selected Indian spices. Prostaglandins Leukot. Essent. Fatty Acids 62:107-110. (Pubitemid 30216389)
66. Shoji S, Furuishi K, Yanase R, Miyazaka T, Kino M. 1993. Allyl compounds selectively killed human immunodeficiency virus (type 1)- infected cells. Biochem. Biophys. Res. Commun. 194:610-621. (Pubitemid 23245179)
67. Spahr A, et al. 2006. Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch. Intern. Med. 166:554 -559.
68. Szabo SE, Monroe SL, Fiorino S, Bitzan J, Loper K. 2004. Evaluation of an automated instrument for viability and concentration measurements of cryopreserved hematopoietic cells. Lab. Hematol. 10:109 -111.
69. Thomson M, Al-Qattan KK, Bordia T, Ali M. 2006. Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J. Nutr. 136(Suppl. 3):800S- 802S.
70. Thomson M, Ali M. 2003. Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Curr. Cancer Drug Targets 3:67- 81.
71. Tsao SM, Hsu CC, Yin MC. 2003. Garlic extract and two diallyl sulphides inhibit methicillin-resistant Staphylococcus aureus infection in BALB/cA mice. J. Antimicrob. Chemother. 52:974 -980.
72. Tsao SM, Liu WH, Yin MC. 2007. Two diallyl sulphides derived from garlic inhibit meticillin-resistant Staphylococcus aureus infection in diabetic mice. J. Med. Microbiol. 56:803- 808.
73. Tsao SM, Yin MC. 2001. In-vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oils. J. Med. Microbiol. 50:646-649.
74. Uchida Y, Takahashi T, Sato N. 1975. [The characteristics of the antibacterial activity of garlic (author's translation)]. Jpn. J. Antibiot. 28:638-642.
75. van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. 2005. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J. Clin. Periodontol. 32:893- 898.
76. Velliyagounder K, et al. 2003. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect. Immun. 71: 6141-6147. (Pubitemid 37337667)
77. Weber ND, et al. 1992. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med. 58:417- 423.
78. Wu D, Cederbaum AI. 2002. Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria. Hepatology 35:1420 -1430.
79. Wu XJ, Hu Y, Lamy E, Mersch-Sundermann V. 2009. Apoptosis induction in human lung adenocarcinoma cells by oil-soluble allyl sulfides: triggers, pathways, and modulators. Environ. Mol. Mutagen. 50:266 -275.
80. Yin MC, Hwang SW, Chan KC. 2002. Nonenzymatic antioxidant activity of four organosulfur compounds derived from garlic. J. Agric. Food Chem. 50:6143- 6147.
81. Zambon JJ. 1985. Actinobacillus actinomycetemcomitans in human periodontal disease. J. Clin. Periodontol. 12:1-20. (Pubitemid 15160467)
82. Zhang T, et al. 2010. Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol. Med. Microbiol. 59:143-151.
83. Zhang YK, Zhang XH, Li JM, Sun DS, Yang Q, Diao DM. 2009. A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide. Anticancer Drugs 20:702-712.